Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market
Holding EWTX?
Track your performance easily

Edgewise Therapeutics (EWTX) Ownership - Who Owns Edgewise Therapeutics?

286 Followers

Edgewise Therapeutics (EWTX) Ownership Overview

32.01%11.94%6.19%9.37%40.48%
32.01% Insiders
6.19% Other Institutional Investors
9.37% ETFs
40.48% Public Companies and
Individual Investors
The ownership structure of Edgewise Therapeutics (EWTX) stock is a mix of institutional, retail, and individual investors. Approximately 27.51% of the company’s stock is owned by Institutional Investors, 32.01% is owned by Insiders, and 40.48% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 24, 2024
xxxxxxxxxxxxx
$3573129
Sep 24, 2024
xxxxxxxxxxxxx
$1996366
Sep 24, 2024
Alan J Russell
Cso,director
xxxxxxxxxxxxx
$2119769
Sep 24, 2024
xxxxxxxxxxxxx
$1220813

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
14,756,096Insider15.74%495,362,143
14,756,096Insider15.74%495,362,143
8,909,091Institution9.50%299,078,185
5,840,059Institution6.23%196,050,781
4,005,787Institution4.27%134,474,270
3,646,341Institution3.89%122,407,667
3,405,800Institution3.63%114,332,706
2,874,586Institution3.07%96,499,852
1,856,417Institution1.98%62,319,919
1,553,661Institution1.66%52,156,400

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,646,341Institution3.89%122,407,667
1,358,867Institution1.45%45,617,165
973,310Institution1.04%32,674,017
828,399Institution0.88%27,809,354
823,885Institution0.88%27,657,819
683,630Institution0.73%22,949,459
593,374Institution0.63%19,919,565
368,928Institution0.39%12,384,913
302,055Institution0.32%10,139,986
206,767Institution0.22%6,941,168

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,537,202Institution2.71%67,717,921
1,871,576Institution2.00%62,828,806
878,208Institution0.94%23,439,372
644,828Institution0.69%21,646,876
414,172Institution0.44%13,903,754
279,282Institution0.30%9,305,676
332,999Institution0.36%8,887,743
164,639Institution0.18%5,485,771
161,441Institution0.17%5,419,574
153,843Institution0.16%5,126,049

FAQ

Who Owns Edgewise Therapeutics (EWTX)?
According to the latest TipRanks data, approximately 6.19% of the company's stock is held by institutional investors, 32.01% is held by insiders, and 40.48% is held by retail investors.
    What percentage of Edgewise Therapeutics (EWTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 6.19% of Edgewise Therapeutics (EWTX) stock is held by institutional investors.
      What percentage of Edgewise Therapeutics (EWTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.48% of Edgewise Therapeutics (EWTX) stock is held by retail investors.
        Who owns the most shares of Edgewise Therapeutics (EWTX)?
        Orbimed Advisors Llc owns the most shares of Edgewise Therapeutics (EWTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis